ZAK is required for doxorubicin, a novel ribotoxic stressor, to induce SAPK activation and apoptosis in HaCaT cells

Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers

(2010) Elena V. Batrakova et al.   JOURNAL OF CONTROLLED RELEASE

Silymarin modulates doxorubicin-induced oxidative stress, Bcl-xL and p53 expression while preventing apoptotic and necrotic cell death in the liver

(2010) Nirav Patel et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Protective effect of tetrahydroxystilbene glucoside on cardiotoxicity induced by doxorubicin in vitro and in vivo

(2009) Shao-hui Zhang et al.   ACTA PHARMACOLOGICA SINICA

Anti-Fas Gene Therapy Prevents Doxorubicin-Induced Acute Cardiotoxicity through Mechanisms Independent of Apoptosis

(2009) Shusaku Miyata et al.   AMERICAN JOURNAL OF PATHOLOGY

Extended kinase profile and properties of the protein kinase inhibitor nilotinib

(2009) Paul W. Manley et al.   BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS

Pretreatment with Statin Attenuates the Cardiotoxicity of Doxorubicin in Mice

(2009) A. Riad et al.   CANCER RESEARCH

Sorafenib

(2009) Gillian M. Keating et al.   DRUGS

Protective effect of creatine against RNA damage

(2009) Carmela Fimognari et al.   MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS

ZAK: a MAP3Kinase that transduces Shiga toxin- and ricin-induced proinflammatory cytokine expression

(2008) Dakshina M. Jandhyala et al.   CELLULAR MICROBIOLOGY

Nilotinib

(2008) M. W. Deininger   CLINICAL CANCER RESEARCH

Small Molecule p38 MAP Kinase Inhibitors for the Treatment of Inflammatory Diseases: Novel Structures and Developments During 2006- 2008

(2008) Liping Pettus et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

New Bcr-Abl inhibitors in chronic myeloid leukemia: keeping resistance in check

(2008) Thomas O'Hare et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

NF-κB Signaling Pathway and Its Therapeutic Implications in Human Diseases

(2008) Fazlul H. Sarkar et al.   INTERNATIONAL REVIEWS OF IMMUNOLOGY

A quantitative analysis of kinase inhibitor selectivity

(2008) Mazen W Karaman et al.   NATURE BIOTECHNOLOGY

Inhibition of p38 MAPK Suppresses Inflammatory Cytokine Induction by Etoposide, 5-Fluorouracil, and Doxorubicin without Affecting Tumoricidal Activity

(2008) Collin R. Elsea et al.   PLoS One

Anti-inflammatory interventions of NF-κB signaling: Potential applications and risks

(2007) Senftleben Uwe   BIOCHEMICAL PHARMACOLOGY

Inhibitors of c-Jun N-terminal kinases—JuNK no more?

(2007) Marie A. Bogoyevitch et al.   BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS